Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant changes in core content or structure are evident between the two screenshots. Only minor, non-functional visual adjustments are visible; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T11:15:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page's related topics section.
    Difference
    0.0%
    Check dated 2025-10-26T04:37:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic: Non-alcoholic fatty liver disease.
    Difference
    0.1%
    Check dated 2025-10-18T00:08:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Major change: update to notice about funding lapse and operating status (core content and proper nouns) plus version bump to v3.2.0.
    Difference
    1%
    Check dated 2025-10-03T12:38:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updated to v3.1.0 and added a new genetics topic: Non-alcoholic fatty liver disease.
    Difference
    0.2%
    Check dated 2025-09-26T07:55:28.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Removed the MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, reducing coverage of that condition on the page.
    Difference
    0.1%
    Check dated 2025-09-19T04:59:16.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.